Check out our most popular compounded medications! Get Started
Codeine Phosphate 60 mg Slow Release Capsules are compounded with Methocel E4M, a controlled-release polymer. This formulation ensures a gradual release of the active ingredient over an extended period, providing sustained therapeutic effects. This reduces the need for frequent dosing and enhances patient compliance.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Codeine Phosphate 60 mg Slow Release Capsules are a prescription medication specifically formulated to manage moderate to severe pain. The capsules are designed with Methocel E4M, a type of controlled-release polymer, which ensures a gradual release of the active ingredient, codeine phosphate, over an extended period. This slow and steady release mechanism provides consistent pain relief throughout the day, reducing the need for frequent dosing and enhancing patient compliance.
Codeine phosphate is an opioid analgesic that functions by inhibiting pain signals from reaching the brain. However, it is crucial to note that this formulation is not intended for the treatment of mild pain, as its effectiveness may not be as pronounced as other medications.
It is imperative to take Codeine Phosphate 60 mg Slow Release Capsules as directed by your healthcare provider. Adherence to the instructions on the label is crucial, and exceeding the recommended dose can lead to severe side effects, including respiratory depression, coma, and even death.
If you have any queries or concerns about Codeine Phosphate 60 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. Our team of experienced compounding pharmacists is always ready to assist you in understanding your medication better and ensuring you get the maximum therapeutic benefit from it.
Codeine Phosphate 60 mg Slow Release Capsules are designed for the treatment of mild to moderate pain, including pain associated with dysmenorrhea, postoperative pain, and cancer pain. The capsules are formulated with Methocel E4M, a controlled-release polymer, which allows for the gradual release of the active ingredient over an extended period of time. This results in sustained therapeutic effects, reduced dosing frequency, and improved patient compliance.
Patients with renal or hepatic impairment should use Codeine Phosphate 60 mg Slow Release Capsules with caution. The same applies to those with a history of substance abuse or addiction. Regular monitoring for signs of respiratory depression, sedation, and constipation is recommended. The medication is contraindicated in patients with a known hypersensitivity to codeine or other opioids.
Additional caution is advised for patients with a history of head injury, increased intracranial pressure, or other conditions that may increase the risk of respiratory depression. The medication may also increase the risk of constipation in patients with a history of gastrointestinal obstruction. Patients with a history of seizure disorder may face an increased risk of seizures when using this medication.
Codeine Phosphate 60 mg Slow Release Capsules should be used with caution in patients with a history of depression, as it may increase the risk of suicidal thoughts or behavior. Patients with a history of cardiovascular disease may face an increased risk of hypotension. The medication may also increase the risk of addiction in patients with a history of drug or alcohol abuse.
If you have any questions about the use of Codeine Phosphate 60 mg Slow Release Capsules, please reach out to your healthcare provider for further guidance.
Codeine Phosphate 60 mg Slow Release Capsules are a potent opioid analgesic medication, primarily used for the management of moderate to severe pain. The mechanism of action involves the inhibition of pain signals travelling between the nerves and the brain, thereby reducing the overall sensation of pain. This particular formulation is designed with Methocel E4M, a type of controlled-release polymer, which allows for the gradual release of the encapsulated medication over an extended period of time. This slow-release mechanism provides a sustained therapeutic effect, reducing the need for frequent dosing and enhancing patient compliance, particularly for medications that necessitate a controlled and prolonged release profile.
However, it is crucial to understand that this formulation is not suitable for treating acute pain due to the time required for the medication to reach its full effect. When taking Codeine Phosphate 60 mg Slow Release Capsules, adherence to the instructions provided by your healthcare provider is of utmost importance. The capsules should be swallowed whole with a glass of water, without chewing, crushing, or breaking them. Consistency in the timing of the dose each day will help ensure a steady level of pain relief.
Like all medications, Codeine Phosphate 60 mg Slow Release Capsules can cause side effects, which may include nausea, constipation, dizziness, and drowsiness. If you experience any of these side effects, it is important to promptly contact your healthcare provider. Always remember to discuss any concerns or questions you may have about Codeine Phosphate 60 mg Slow Release Capsules with your healthcare provider or pharmacist.
Codeine Phosphate 60 mg Slow Release Capsules is a medication that contains the active ingredient Codeine Phosphate. It is formulated with Methocel E4M, a type of controlled-release polymer, which allows the medication to be released gradually over an extended period of time.
The controlled-release polymer, Methocel E4M, is designed to release the encapsulated medication gradually over an extended period of time. This offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
Due to the slow-release formulation, the frequency of dosing is reduced. However, the exact frequency will depend on your doctor's prescription. Always follow the instructions provided by your healthcare provider.
Slow-release capsules offer several benefits. They provide sustained therapeutic effects over an extended period of time, reduce the frequency of dosing, and improve patient compliance, especially for medications that require a controlled and prolonged release profile.
The active ingredient in Codeine Phosphate 60 mg Slow Release Capsules is Codeine Phosphate.
No, breaking or crushing the capsule can interfere with the slow-release mechanism and may lead to the rapid release of a potentially fatal dose of Codeine Phosphate.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up.
Side effects may include constipation, nausea, sleepiness, and confusion. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
No, alcohol can increase the risk of serious side effects such as respiratory depression and sedation. It is recommended to avoid alcohol while taking this medication.
Codeine Phosphate can pass into breast milk and may harm a nursing baby. It may also cause withdrawal symptoms in a newborn if the mother takes the medication during pregnancy. Always consult your healthcare provider before taking any medication if you are pregnant or breastfeeding.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
